Information Provided By: 
Fly News Breaks for August 5, 2019
RGEN
Aug 5, 2019 | 09:06 EDT
Craig-Hallum analyst Matt Hewitt raised his price target for Repligen to $108 from $80 saying that while the expectations were high going into the company's Q2 earnings report following a better than expected prerelease, the results didn't disappoint, with organic growth of 40%-plus across all three of its largest segments. The analyst reiterates a Buy rating on the shares.
News For RGEN From the Last 2 Days
There are no results for your query RGEN
